| Literature DB >> 20011280 |
Abstract
Ulcerative colitis is a chronic inflammatory disease of the colon with an increasing incidence worldwide. The medical management of this disease continues to expand as drugs to induce and maintain remission are sought to avoid the need for colectomy. This article will review the standard of care for the treatment of mild, moderate, and severe ulcerative colitis. The efficacy, optimal usage, and adverse events profile of agents such as 5-aminosalicylates, corticosteroids, azathioprine, and cyclosporine will be discussed and an algorithm for their use will be developed. Alternative and experimental therapies such as monoclonal antibodies, probiotics, and heparin will also be addressed.Entities:
Keywords: Ulcerative colitis; cyclosporine; medical therapy
Year: 2004 PMID: 20011280 PMCID: PMC2780076 DOI: 10.1055/s-2004-823066
Source DB: PubMed Journal: Clin Colon Rectal Surg ISSN: 1530-9681